ID: ALA365481

Max Phase: Preclinical

Molecular Formula: C12H11N3

Molecular Weight: 197.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1[nH]c(N)cc2nc3ccccc3c1-2

Standard InChI:  InChI=1S/C12H11N3/c1-7-12-8-4-2-3-5-9(8)15-10(12)6-11(13)14-7/h2-6,14H,13H2,1H3

Standard InChI Key:  NZFKVLPYMQSGMW-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrofolate reductase 1810 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 197.24Molecular Weight (Monoisotopic): 197.0953AlogP: 2.56#Rotatable Bonds: 0
Polar Surface Area: 54.70Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.94CX Basic pKa: 4.51CX LogP: 2.05CX LogD: 2.05
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.58Np Likeness Score: -0.86

References

1. Parenti MD, Pacchioni S, Ferrari AM, Rastelli G..  (2004)  Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.,  47  (17): [PMID:15293997] [10.1021/jm040769c]

Source